Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions. The solution is free of unconjugated Brilliant Violet 421™ and unconjugated antibody.
Storage & Handling:
The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤5 µl per million cells or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
Human peripheral blood lymphocytes were surface stained with CD3 APC and then intracellularly stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ (bottom).
T-bet, also known as T-box transcription factor T-bet, is considered to be a "master regulator" of Th1 lymphoid development controlling the production of the cytokine IFN-γ. T-bet is widely expressed in hematopoietic cells including stem cells, NK cells, B cells, and T cells. T-bet is critical for the control of microbial pathogens, and knockout animals show multiple physiologic and inflammatory features characteristic of asthma. T-bet expression is optimally observed after IL-12 stimulation and can be suppressed by addition of the Th2 cytokine IL-4 or neutralization of IL-12.
Other Names:
T box expressed in T cells, T box 21, TBLYM
Structure:
T-box transcription factor, approximately 58 kD.
Distribution:
Nuclear; expressed in T cells, hematopoietic stem cells, NK cells, B cells, lung, spleen.
Function:
Th1-specific T-box transcription factor controlling expression of the hallmark Th1 cytokine, interferon gamma (IFN-γ). T-bet expression is critical for the control of microbial pathogens.
Antigen References:
1. Szabo SJ, et al. 2000. Cell 100:655. 2. Szabo SJ, et al. 2002. Science 295:338. 3. Finotto S, et al. 2002. Science 295:336. 4. Mullen AC, et al. 2001. Science 292:1907.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.
APC anti-T-bet
Human peripheral blood lymphocytes surface stained with CD3 PE then intracellularly stained with T-bet (clone 4B10) APC (top) or mouse IgG1 APC isotype control (bottom).
Purified anti-T-bet
Human Th1 (left) and mouse Th1 (right) cell lysates were resolved by electrophoresis, transferred to nitrocellulose and probed with purified 4B10. Proteins were visualized using a HRP goat anti-mouse secondary antibody and a chemiluminescent system.
Alexa Fluor® 647 anti-T-bet
PMA/ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with IFN-γ (4S.B3) FITC and 4B10 Alexa Fluor® 647
PerCP/Cy5.5 anti-T-bet
PMA/ionomycin-stimulated (6 hours) human peripheral blood lymphocytes intracellularly stained with CD3 PE (UCHT1) and 4B10 PerCP/Cy5.5
Pacific Blue™ anti-T-bet
Human peripheral blood lymphocytes surface stained with CD3 (UCHT1) FITC and then intracellularly stained with 4B10 Pacific Blue™
PE anti-T-bet
Human peripheral blood lymphocytes surface stained with CD3 (UCHT1) FITC then intracellular stained with 4B10 PE (top) or mIgG1,k PE isotype control (bottom)
Brilliant Violet 711™ anti-T-bet
Human peripheral blood mononuclear cells were surface stained with CD3 PE, and then intracellularly stained with T-bet (clone 4B10) Brilliant Violet 711™ (top) or mouse IgG1, κ Brilliant Violet 711™ (bottom).
FITC anti-T-bet
Human peripheral blood lymphocytes intracellularly stained with 4B10 FITC (top) or mouse IgG1,k isotype control (bottom) and CD3 APC
Brilliant Violet 421™ anti-T-bet
Human peripheral blood lymphocytes were surface stained with CD3 APC and then intracellularly stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ (bottom).
Brilliant Violet 605™ anti-T-bet
Human peripheral blood lymphocytes were surface stained with CD3 PE, and then intracellularly stained with T-bet (clone 4B10) Brilliant Violet 605™.
PE/Cy7 anti-T-bet
Human peripheral blood lymphocytes were surface stained with CD3 FITC, and then intracellularly stained with T-bet (clone 4B10) PE/Cy7 (top) or mouse IgG1, κ PE/Cy7 (bottom).
